Fig. 4From: Chemosensitivity to doxorubicin in primary cells derived from tumor of FVB/N-Trp53tm1Hw1 with TALEN-mediated Trp53 mutant geneCell cycle analysis after DOX treatment. The cell cycle was analyzed by flow cytometric analysis of the DNA content of nuclei of cells following staining with propidium iodide. After treatment with DOX, the number of cells in the G0/G1, S and G2/M stage was determined at each time point A. Data of FACS analysis of CT26 cells, solid tumor cells and ascetic tumor cells at 0 and 24 h B. The data presented represents the means ± SD (n = 3). *, p < 0.05 relative to the CT26 cellsBack to article page